Reactome | Tankyrase ADP-ribosylates AXIN

Tankyrase ADP-ribosylates AXIN

Stable Identifier

R-HSA-3640858

Type

Reaction [transition]

Species

Homo sapiens

Compartment

cytosol

ReviewStatus

5/5

Locations in the PathwayBrowser

Expand all

General

SBML | | PDF

SVG | | PPTX | SBGN

Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

TNKS1 and 2 function redundantly to control AXIN protein levels through the addition of poly-ADP-ribosyl groups (PARSylation), which may lead to subsequent ubiquitination and degradation by the proteasome. In HEK293, SW480 and breast cancer cell lines, depletion of TNKS1 and 2 increases the protein levels of AXIN1 and AXIN2 resulting in increased beta-catenin phosphorylation, decreased beta-catenin abundance and decreased expression of WNT targets and WNT-responsive reporters (Huang et al, 2009; Callow et al, 2011; Waaler et al, 2012; Bao et al, 2012). In vitro, TNKS2 catalyzes the addition of ADP-ribosyl groups to the TBD fragment of AXIN1, while in vivo, both exogenous GST-AXIN1 and endogenous AXIN1 are PARSylated in a TNKS-dependent manner (Huang et al, 2009; Callow et al, 2011; Zhang et al, 2011). PARSylation is likely required for the subsequent proteasome-mediated degradation of AXIN, as the increase in levels of polyubiquitinated AXIN1 and 2 seen upon treatment of cells with the proteasome inhibitor MG132 is lost if cells are simultaneously treated with an inhibitor of TNKS1 and 2 (Huang et al, 2009). Although in this reaction, TNKS is shown PARSylating unbound AXIN, it is likely that this regulation occurs at the level of the destruction complex. Also not shown in this reaction is the ability of TNKS to catalyze autoPARSylation reactions, which ultimately lead to its own degradation (Yeh et al, 2006; Huang et al, 2009; Zhang et al, 2011).

Literature References

PubMed ID	Title	Journal	Year
21478859	RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling Mickanin, C, Zhang, Y, Shi, X, Charlat, O, Feng, Y, Cong, F, Schirle, M, Michaud, GA, Hild, M, Porter, JA, Bauer, A, Huang, SM, Myer, VE, Finan, PM, Liu, S	Nat. Cell Biol.	2011
19759537	Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling Mickanin, C, Zhang, Y, Fawell, S, Mishina, YM, Fazal, A, Myer, V, Wiellette, E, Michaud, GA, Wiessner, S, Hild, M, Bauer, A, Porter, JA, Rau, C, Huang, SM, Lengauer, C, Finan, PM, Ghidelli, S, Serluca, F, Shao, W, Bouwmeester, T, Shi, X, Stegmeier, F, Shultz, M, Charlat, O, Kirschner, MW, Cong, F, Schirle, M, Schlegl, J, Curtis, D, Wilson, CJ, Tallarico, JA, Cheng, H, Cheung, A, Liu, S, Lu, C, Tomlinson, R	Nature	2009
16884355	Tankyrase recruitment to the lateral membrane in polarized epithelial cells: regulation by cell-cell contact and protein poly(ADP-ribosyl)ation Tsun, ZY, Yeh, TY, Lee, RM, Meyer, TN, Schwesinger, C, Chi, NW	Biochem. J.	2006
22440753	A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice Wilson, SR, Machon, O, Korinek, V, Waaler, J, Dinh, H, Machonova, O, Krauss, S, Eide, TJ, Tumova, L, Voronkov, A, von Kries, JP, Paulsen, JE, Gradl, D, Pedersen, NM	Cancer Res.	2012
21799911	Ubiquitin ligase RNF146 regulates tankyrase and Axin to promote Wnt signaling Kirkpatrick, DS, Bheddah, S, Lau, T, Callow, MG, Lee, J, Davis, D, Sandoval, WN, Polakis, P, Tran, H, Lill, JR, Hongo, JA, Costa, M, Liu, PS, Tao, J, Phu, L	PLoS ONE	2011
23144924	Inhibition of tankyrases induces Axin stabilization and blocks Wnt signalling in breast cancer cells Christova, T, Yan, X, Song, S, Angers, S, Attisano, L, Bao, R	PLoS ONE	2012